Page 43 - MDAnderson Memoria 2018

Número de ensayos clínicos y estudios observacionales iniciados por año
Number of clinical trials and observational studies launched by year
E.C. y E.O. iniciados anualmente / C.T. and O.S. launched yearly
Listado de ensayos clínicos iniciados en 2017
List of clinical trials started in 2017
43
32 33
28
32
32
31
27 27
22
12
27
1
3
6 4
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
CÓDIGO ENSAYO CLÍNICO
TRIAL CODE
PROMOTOR
PROMOTOR
TÍTULO ENSAYO CLÍNICO
TITLE CLINICAL TRIAL
INVESTIGADOR PRINCIPAL
PRINCIPAL INVESTIGATOR
ACT14884
SANOFI
Open-label phase 2 study evaluating efficacy and safety of SAR566658 treatment in patients with CA6 positive metastasic triple negative breast cancer
Dr. Antonio González
SOLTI-1402 (CORALLEEN)
SOLTI
A Phase 2 Clinical Trial of multi-agent Chemotherapy or letrozole plus Ribociclib (LEE011) as neoadjuvant treatment for postmenopausal patients with Luminal B/HER2-negative breast cancer
Dr. Raquel Bratos
GEICAM 2015/06 COMETA Breast
GEICAM
A Phase II Clinical Trial to analyse Olaparib Response in patients with BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer"
Dr. Raquel Bratos
PR-30-5017-C
TESARO
Estudio de fase 3, aleatorizado, en doble ciego,
controlado con placebo y multicéntrico, del tratamiento de mantenimiento con niraparib en pacientes con cáncer de ovario avanzado portador de deficiencia de la recombinación homóloga (HRD) que han respondido a la quimioterapia de primera línea con platino
Phase 3, randomized, double blind study, controlled with placebo, multicenter, on maintenance treatment with niraparib in patients with HRD positive advanced ovarian cancer who responded to first line chemotherapy with platinum
Dr. Antonio González
CO-338-043 (ARIEL-4)
Clovis Oncology
ARIEL4 (Assessment of Rucaparib In Ovarian CancEr TriaL): A Phase 3 Multicenter, Randomized Study of Rucaparib versus Chemotherapy in Patients with Relapsed, BRCA-Mutant, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Dr. Antonio González